NSE / BSEHealthcare
₹1595.15+13.05+0.82%
P/E49.8Mkt Cap₹17.35 K CrEV/EBITDA42.5

Poly Medicure Ltd

P/E49.8Mkt Cap₹17.35 K CrEV/EBITDA42.5
Company Profile

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

Valuation

Market Cap
₹0.00
Current Price
₹0
as of 16 Oct 2026
P/E Ratio
0.0x
P/B Ratio
0.0x
EV / EBITDA
0.0x
EV / Sales
0.0x
52W High
₹0
52W Low
₹0
Shares Out
0.00 Cr

Profitability

Operating Margin
0.0%
Net Profit Margin
0.0%
EBITDA Margin
0.0%

Returns

ROE
0.0%
ROCE
0.0%
ROIC %
—
ROA
0.0%
Dividend Payout
0.0%

Solvency

Current Ratio
0.0x
Debt / Equity
0.0x
Debt / Assets
0.0x
CFO / Net Profit
0.0x
Interest Coverage
0.0x

AI Summary

Indian Stock

Strengths1

  • Strong 5-year revenue CAGR of 15.1%

Concerns1

  • Negative free cash flow (₹2 Cr)

Rule-based from financial data. Not advice.

Price History▼ 16.80% over 1Y

Monthly Returns

Unlock Monthly Returns

Available on Pro and Institutional plans.

Sign up free

Year-to-Date ROI

Unlock Year-to-Date ROI

Available on Pro and Institutional plans.

Sign up free

Historical Volatility

Unlock Historical Volatility

Available on Pro and Institutional plans.

Sign up free

Historical Performance

Revenue, profitability, and cash flow trends (₹ Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenue₹1.60 K Cr▲ 22.6%
EBITDA Growth—
Net Profit₹331.00 Cr▲ 31.3%
Cash from Ops (CFO)—
Free Cash Flow (FCF)—▼ 200.0%
Revenue CAGR 5Y15.1%
EBITDA CAGR 5Y17.7%
Net Profit CAGR 5Y22.3%
NP Growth 1Y31.3%

Historical Growth

Year-by-year revenue, profitability, and cash flow (₹ Crores, last 1 year)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025₹1.60 K Cr—₹331.00 Cr——12.1%22.6%31.3%

Showing the latest year only. Sign up free for the full history.

Financial Statements

Income statement, balance sheet, and cash flow (₹ Crores, as reported)

Showing the latest year only. Sign up free for the full history.

Consolidated Figures in USD Millions.

Unnamed: 0TTM
Revenue / Net Sales1,632
Total Expenses1,189
EBIT / Operating Profit444
OPM %27%
Other Income121
Finance Costs11
Depreciation & Amortisation89
Profit Before Tax465
Tax %-
Net Profit / PAT349
EPS (₹)34.42
Dividend Payout %-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Poly Medicure Ltdthis co.₹17.35 K Cr₹1.60 K Cr49.806.0142.4822.6%
Sun Pharmaceutical Industries Ltd.₹4.15 L Cr₹23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.₹1.71 L Cr₹9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.₹1.33 L Cr₹9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.₹1.17 L Cr₹19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.₹1.05 L Cr₹8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limited₹1.00 L Cr₹2.66 K Cr144.0011.7696.8413.8%
Industry Average—₹3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Poly Medicure Ltd and the metrics that matter.

Browse the full Equiscale Academy